RhNGF slow unfolding is not due to proline isomerization: Possibility of a cystine knot loop-threading mechanism

Protein Science

Volumn 5, Issue 8, 1996, Pages 1554-1566

  De Young, Linda R ^a   Burton, Louis E ^a   Liu, Jun ^a   Powell, Michael F ^a   Schmelzer, Charles H ^a   Skelton, Nicholas J ^a  

^a GENENTECH INC   (United States)

Author keywords

cystine knot; loop threading; neurotrophin; NGF; proline isomerization; protein folding; slow folding

Indexed keywords

NERVE GROWTH FACTOR BETA SUBUNIT;

AMINO ACID SEQUENCE; ARTICLE; CONFORMATIONAL TRANSITION; ISOMERISM; PRIORITY JOURNAL; PROTEIN DENATURATION; PROTEIN FOLDING;

EID: 0030037084     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1002/pro.5560050811     Document Type: Article

References (39)

1. Barbacid M. 1994. The trk-family of neurotrophin receptors. J Neurobiol 25:1386-1403
2. Bothwell M, Shooter EM. 1977. Dissociation equilibrium constant of β nerve growth factor. J Biol Chem 252:8532-8536.
3. Brandts JF, Halvorson HR, Brennan M. 1975. Consideration of the possibility that the slow step in protein denaturation reactions is due to cis-trans isomerism of proline residues. Biochemistry 14:4953-4963.
4. Burton LE, Schmelzer CH, Szonyi E, Yedinak C, Gorrell A. 1992. Activity and biospecificity of proteolyzed forms and dimeric combinations of recombinant human and murine nerve growth factor. J Neurochem 59:1937-1945.
5. Corbett RJT, Roche RS 1984. Use of high-speed size-exclusion chromatography for the study of protein folding and stability. Biochemistry 23:1888-1894.
6. Dill KA, Shortle D. 1991. Denatured states of proteins. Annu Rev Biochem 60:795-825.
7. Gilbert HF. 1990. Molecular and cellular aspects of thiol-disulfide exchange. Adv Enzymol 63:69-172.
8. Herning T, Yutani K, Taniyama Y, Kikuchi M. 1991. Effects of Proline mutations on the unfolding and refolding of human lysozyme: The slow refolding kinetic phase does not result from proline cis-trans isomerization. Biochemistry 30:9882-9891.
9. Herold M, Leistler B. 1991. Unfolding of truncated and wild type aspartate aminotransferase studied by size-exclusion chromatography. J Chromatog 539:383-391.
10. Johnson ML, Correia JJ, Yphantis DA, Halvorson HR. 1981. Analysis of data from the analytical ultracentrifuge by nonlinear least-squares techniques. Biophys J 36:575-588.
11. Kolbeck R, Jungbluth S, Barde YA. 1994. Characterisation of neurotrophin dimers and monomers. Eur J Biochem 225:995-1003.
12. Lakowicz JR. 1983. Principles of fluorescence spectroscopy New York: Plenum Press. p 356.
13. Lee JC, Timasheff SN. 1979. The calculation of partial specific volumes of proteins in 6 M guanidine hydrochloride. Methods Enzymol 61:49-51.
14. McDonald CC, Phillips WD, Glickson JD. 1971. Nuclear magnetic resonance study of the mechanism of reversible denaturation of lysozyme. J Am Chem Soc 93:235-246.
15. McDonald NQ, Hendrickson WA. 1993. A structural superfamily of growth factors containing a cystine knot motif. Cell 73:421-424.
16. McDonald NQ, Lapatto R, Murray-Rust J, Gunnij J, Wlodawer A, Blundell TL. 1991. New protein fold revealed by a 2.3-Å resolution crystal structure of nerve growth factor. Nature (Lond) 354:411-414.
17. Murray-Rust J, McDonald NQ, Blundell TL, Hosang M, Oefner C, Winkler F, Bradshaw RA. 1993. Topological similarities in TGF-b2, PDGF-BB and NGF define a superfamily of polypeptide growth factors. Structure I:153-159.
18. Nandi PK, Robinson DR. 1984. Effects of urea and guanidine hydrochloride on peptide and nonpolar groups. Biochemistry 23:6661-6668.
19. Palleros DR, Shi L, Reid KL, Fink AL. 1993. Three-state denaturation of DnaK induced by guanidine hydrochloride. Evidence for an expandable intermediate. Biochemistry 32:4314-4321
20. Pardi A, Wagner G, Wüthrich K. 1983. Protein conformation and proton nuclear-magnetic-resonance chemical shifts. Eur J Biochem 137:445-454.
21. Philo JS, Rosenfeld R, Arakawa T, Wen J, Narhi LO. 1993. Refolding of brain-derived neurotrophic factor from guanidine hydrochloride: Kinetic trapping in a collapsed form which is incompetent for dimerization. Biochemistry 32:10812-10818.
22. Radziejewski C, Robinson RC, DiStefano PS, Taylor JW. 1992. Dimeric structure and conformational stability of brain-derived neurotrophic factor and neurotrophin-3. Biochemistry 31:4431-4436.
23. Rance M, Byrd RA. 1983. Obtaining high fidelity spin 1/2 powder spectra in anisotropic media: Phase cycled Hahn-echo spectroscopy. J Magn Reson 52:221-240.
24. Robinson DR, Jencks WP. 1965. The effect of compounds of the urea-guanidinium class on the activity coefficient of acetyltetraglycine ethyl ester and related compounds. J Am Chem Soc 87:2462-2470.
25. Robinson RC, Radziejewski C, Stuart DI, Jones EY. 1995. Structure of the brain-derived neurotrophic factor/neurotrophin 3 heterodimer. Biochemistry 34:4139-4146.
26. Rosenfeld R, Benedek K. 1993. Conformational changes of brain-derived neurotrophic factor during reversed-phase high-performance liquid chromatography. J Chromatog 632:29-36.
27. Schmelzer CH, Burton LE, Chan WP, Martin E, Gorman C, Canova-Davis E, Ling VT, Sliwkowski MB, McCray G, Briggs JA, Nguyen TH, Polastri G. 1992. Biochemical characterization of recombinant human nerve growth factor. J Neurochem 59:1675-1683.
28. Schmid FX. 1992 Kinetics of unfolding and refolding of single-domain proteins. In: Creighton TE, ed. Protein folding. New York: W.H. Freeman and Company. pp 197-241.
29. Schmid FX, Baldwin RL. 1979. The rate of interconversion between the two unfolded forms of ribonuclease A does not depend on guanidinium chloride concentration. J Mol Biol 133:285-287.
30. Shalongo W, Jagannadham MV, Flynn C, Stellwagen E. 1989. Refolding of denatured ribonuclease observed by size exclusion chromatography. Biochemistry 28:4820-4825.
31. Shin A, Laramee GR, Schmelzer CH, Burton LE, Winslow JW. 1994. Mutagenesis identifies amino-terminal residues of nerve growth factor necessary for Trk receptor binding and biological activity. J Biol Chem 269:27679-27686.
32. Shortle D, Meeker AK. 1989. Residual structure in large fragments of staphylococcal nuclease: Effects of amino acid substitutions. Biochemistry 28:936-944.
33. Szilágyi L, Jardetzky O. 1989. α-Proton chemical shifts and secondary structure in proteins. J Magn Res 83:441-449.
34. Timm DE, de Haseth PL, Neet KE. 1994 Comparative equilibrium denaturation studies of the neurotrophins: Nerve growth factor, brain-derived neurotrophic factor, neurotrophin 3, and neurotrophin 4/5. Biochemistry 33:4667-4676.
35. Timm DE, Neet KE. 1992. Equilibrium denaturation studies of mouse β-nerve growth factor. Protein Sci 1:236-244.
36. Ullrich A, Gray A, Berman C, Dull TJ. 1983. Human β-nerve growth factor gene sequence highly homologous to that of mouse. Nature 303: 821-825.
37. Wishart DS, Sykes BD, Richards FM. 1991. Relationship between nuclear magnetic resonance chemical shift and protein secondary structure. J Mol Biol 222:311-333.
38. Withka J, Moncuse P, Baziotis A, Maskiewicz R. 1987. Use of high-performance size-exclusion, ion-exchange, and hydrophobic interaction chromatography for the measurement of protein conformational change and stability. J Chromatog 398:175-202.
39. 2-terminal residues of nerve growth factor affects activity and Trk binding without affecting stability or conformation J Biol Chem 270:6278-6285.